Tanisawa K, Ito T, Sun X, Ise R, Oshima S, Cao ZB, Sakamoto S, Tanaka M, Higuchi M. High cardiorespiratory fitness can reduce glycated hemoglobin levels regardless of polygenic risk for Type 2 diabetes mellitus in nondiabetic Japanese men. Physiol Genomics 46: 497-504, 2014. First published May 13, 2014 doi:10.1152/physiolgenomics.00027.2014.-High cardiorespiratory fitness (CRF) is associated with a reduced risk of Type 2 diabetes mellitus (T2DM) and improved ␤-cell function; genetic factors also determine these risks. This cross-sectional study investigated whether CRF modifies the association of polygenic risk of T2DM with glucose metabolism in nondiabetic Japanese men. Fasting plasma glucose, insulin, and glycated hemoglobin (HbA1c) levels were measured in 174 Japanese men (age: 20 -79 yr). ␤-Cell function and insulin resistance were evaluated by calculating HOMA-␤ and HOMA-IR, respectively. CRF was assessed by measuring maximal oxygen uptake (V O2max). Subjects were divided into the low and high CRF groups within each age group according to the median V O2max. Eleven single nucleotide polymorphisms (SNPs) associated with T2DM were analyzed and used to calculate genetic risk score (GRS); subjects were divided into the low, middle, and high GRS groups. The high GRS group had higher HbA1c levels than the low GRS group in both the low and high CRF groups (P Ͻ 0.05). Furthermore, the individuals with a high GRS had a lower HOMA-␤ than those with a low GRS regardless of CRF (P Ͻ 0.05). In multiple linear regression analysis, although GRS was a significant predictor of HbA1c (␤ ϭ 0.153, P ϭ 0.025), V O2max was also associated with HbA1c (␤ ϭ Ϫ0.240, P ϭ 0.041) independent of GRS. These results suggest that CRF is associated with HbA1c levels independent of GRS derived from T2DM-related SNPs; however, it does not modify the association of GRS with increased HbA1c or impaired ␤-cell function. cardiorespiratory fitness; polygenic risk; HbA1c; ␤-cell function TYPE 2 DIABETES MELLITUS (T2DM) affects more than 300 million people worldwide, and its prevalence is increasing significantly in many countries including Japan (55). Although the etiology of T2DM differs slightly among ethnic groups (30), impaired insulin secretion and insulin resistance are the main pathophysiological components and are influenced by multiple genetic and environmental factors (14, 24).
TYPE 2 DIABETES MELLITUS (T2DM) affects more than 300 million people worldwide, and its prevalence is increasing significantly in many countries including Japan (55) . Although the etiology of T2DM differs slightly among ethnic groups (30) , impaired insulin secretion and insulin resistance are the main pathophysiological components and are influenced by multiple genetic and environmental factors (14, 24) .
Recent genome-wide association studies (GWASs) identified single nucleotide polymorphisms (SNPs) at several genetic loci that are associated with susceptibility to T2DM in European and Asian populations (15, 38, 41, 51, 57) . Several of them are associated with impaired ␤-cell function, whereas relatively few SNPs are associated with insulin resistance, particularly in Asian populations. To examine the polygenic risk of the incidence of T2DM with respect to these SNPs, several studies calculated the genetic risk score (GRS) from the number of risk alleles per individual and demonstrated that the GRS is more strongly associated with the risk of T2DM than single SNPs (32, 33, 47) . Interestingly, Iwata et al. (23) demonstrated that the GRS calculated using ␤-cell functionrelated SNPs is more strongly associated with susceptibility to T2DM than the GRS from insulin resistance-related SNPs in a Japanese population. Furthermore, several studies reported that the accumulation of risk alleles for ␤-cell function-related SNPs is associated with impaired ␤-cell function even in individuals without diabetes (18, 36, 44, 49a) . Therefore, because impaired insulin secretion is a predominant risk factor for T2DM in Asian populations (30, 34) , early intervention is needed even in nondiabetic Asian individuals with a high genetic risk of impaired ␤-cell function.
In contrast, several studies demonstrated that increased physical activity increases cardiorespiratory fitness (CRF) and reduces the risk of T2DM (19, 37) . In accordance with epidemiological evidence, several studies confirmed that regular exercise improved ␤-cell function as well as insulin resistance in humans (13, 31, 42) . Therefore, physically active individuals with high CRF may attenuate their genetic risks of T2DM and impaired ␤-cell function, even though CRF per se is partly determined by certain genetic components (10, 11) , some of which are also associated with insulin sensitivity and the conversion from impaired glucose tolerance to T2DM (5, 45) . Previous studies have investigated whether increased selfreported physical activity modifies the associations of T2DM-related SNPs with the incidence of T2DM and impaired glucose tolerance; however, contradictory results have been reported (12, 26, 39) . CRF is thought to be a more accurate predictor of health outcomes than self-reported physical activity because it is a more stable physiological measure that reflects recent physical activity patterns (8, 46) . Therefore, the interaction effects between T2DM-related SNPs and CRF also should be examined. Moreover, these previous studies only focused on single SNPs, which have small effects by themselves. It is necessary to determine whether high CRF diminishes the polygenic risk of T2DM.
In the present study, we calculated GRS on the basis of the SNPs associated with T2DM. We examined the effects of CRF on the relationships of GRS with glycated hemoglobin (HbA1c), insulin resistance, and ␤-cell function in Japanese men without diabetes.
MATERIALS AND METHODS

Subjects.
One hundred seventy-four Japanese men aged 20 -79 yr participated in this study. The subjects were instructed not to engage in any intensive exercise for 2 days before the experiment. We excluded subjects with T2DM in accordance with the World Health Organization criteria (4) . Subjects were also excluded if they had a history of cardiovascular diseases or other chronic diseases such as Type 1 diabetes, cancer, chronic renal failure, nonalcoholic steatohepatitis, or autoimmune disorders. We also recorded medication use including antihypertensive and lipid-lowering drugs that potentially affect glucose metabolism; 34 subjects (19.5%) were treated with such drugs. Current/former smoking status was assessed by a questionnaire. Daily alcohol and saturated fat intakes were assessed by a brief-type self-administered diet history questionnaire (28) . All subjects provided written informed consent before enrollment in the study, which was approved by the Ethical Committee of Waseda University. The study was conducted in accordance with the Declaration of Helsinki.
Anthropometric characteristics. Body weight and body fat percentage were measured by an electronic scale (Inner Scan BC-600; Tanita, Tokyo, Japan), whereas height was measured by a stadiometer (YL-65; Yagami, Nagoya, Japan). Body mass index (BMI) was calculated from measurements of body weight, and height. Visceral fat area was measured by magnetic resonance imaging (MRI) (Signa 1.5T; General Electric, Milwaukee, WI). The imaging conditions included a T1-weighted spin-echo and axial-plane sequence with a slice thickness of 10 mm, repetition time of 140 ms, and echo time of 12.3 ms (6, 50) . Cross-sectional images were scanned at the umbilical region. During the scan, the subjects were asked to hold their breath for ϳ30 s after inhaling to reduce respiratory motion artifacts. MR images were transferred to a personal computer in the Digital Imaging and Communications in Medicine file format, and the cross-sectional area of the visceral fat at the umbilical region was determined using imageanalysis software (Slice-o-matic 4.3 for Windows; Tomovision, Montreal, Canada). To minimize interobserver variation, all analyses were performed by the same investigator; the coefficient of variation was 0.4% for the cross-sectional areas of the umbilical region.
CRF. CRF was assessed by a maximal graded exercise test using a cycle ergometer (Ergomedic 828E; Monark, Varberg, Sweden) and quantified as maximal oxygen uptake (V O2max). The graded cycle exercise began at a workload of 45-90 W, which was increased by 15 W every minute until the subject could no longer maintain the required pedaling frequency of 60 rpm. Heart rate and ratings of perceived exertion were monitored each minute during exercise. During the incremental portion of the exercise test, expired gas was collected from the subjects. O 2 and CO2 concentrations were measured and averaged over 30 s intervals by an automated gas analyzer (Aeromonitor AE-300; Minato Medical Science, Tokyo, Japan). The maximum V O2 recorded during the exercise test was considered the V O2max (ml·kg Ϫ1 ·min Ϫ1 ), and the achievement of V O2max was accepted if at least three of the following four criteria were met: the V O2 curve showed a plateau despite increasing the work rate, maximal heart rate was 95% of the age-predicted maximal heart rate (220 Ϫ age [in years]), respiratory exchange ratio Ͼ Physical activity. Physical activity was measured by a uniaxial accelerometer (Kenz Lifecorder EX; Suzuken, Nagoya, Japan). The subjects were instructed how to use the accelerometer before the test period; they continuously wore it on their belt or waistband at the right midline of the thigh for 10 days, except when sleeping or bathing. As indexes of physical activity, moderate-intensity physical activity (MPA) and vigorous-intensity physical activity (VPA) were determined from 7 days of accelerometer data (5 weekdays and 2 weekend days) as described previously (29) . As several activities such as swimming, cycling, and rowing cannot be assessed by an accelerometer, subjects also recorded leisure time physical activities performed during 10 days in a questionnaire. We calculated the self-reported times spent performing MPA and VPA on the basis of the metabolic equivalents of each activity (3) and added them to the accelerometermeasured MPA and VPA. Valid physical activity data were obtained from 154 (88.5%) participants and analyzed.
Blood sample collection and analysis. Blood samples were collected between 08:30 AM and 11:00 AM after a 12 h overnight fast and subsequently centrifuged at 3,000 g for 15 min at 4°C. Serum and plasma were stored at Ϫ80°C until analysis. The levels of fasting plasma glucose (FPG), insulin, HbA1c, total cholesterol, HDL cholesterol, LDL cholesterol, and triglycerides were determined by BML (Tokyo, Japan). The homeostasis model assessment of insulin resistance (HOMA-IR) was used as an index of insulin resistance; it was calculated from the fasting concentrations of plasma glucose and serum insulin as follows: HOMA-IR ϭ [fasting glucose (mg/dl)] ϫ [fasting insulin (U/ml)]/405. Insulin secretory capacity and ␤-cell function were evaluated by the homeostasis model assessment of ␤-cell function (HOMA-␤), which was calculated as follows:
SNP selection. We selected a total of 11 SNPs at genetic loci previously shown to be robustly associated with T2DM in Japanese populations (Table 1) (20, 21, 48, 57) . All of these loci have been used to calculate GRS for T2DM or ␤-cell function in several previous studies (23, 44, 49a) . All selected SNPs were in Hardy-Weinberg equilibrium (P Ͼ 0.05) ( Table 1) .
SNP genotyping. Nuclear DNA was extracted from peripheral blood using the QIAamp DNA Mini kit (QIAGEN, Hilden, Germany), and DNA quality was evaluated by agarose gel electrophoresis and spectrophotometry. We confirmed that none of the DNA samples was fragmented and that the A260/A280 ratio was 1.8 -2.0. SNP genotyping was performed using the Infinium HumanExome BeadChip version 1.1 (Illumina, San Diego, CA) according to the manufacturer's protocol. Genotype calling was performed using the GenTrain clustering algorithm (version 1.0) in GenomeStudio (version 2011.1, Illumina). Cluster boundaries were determined using the standard cluster files provided by Illumina. The SNP call rate was at least 98.7% for all samples.
GRS calculation. We calculated GRS on the basis of the 11 selected SNPs. We assumed that each SNP acts in an additive manner; therefore, the GRS was calculated by adding the risk allele number of each SNP. We divided subjects into the low, middle, and high GRS groups for subsequent analysis. The ranges for the low, middle, and high GRS groups were 4 -7, 8 -10, and 11-15, respectively.
Statistical analysis. All statistical analyses were performed with SPSS version 21.0 (SPSS, Chicago, IL) or PLINK version 1.07 (Massachusetts General Hospital, Boston, MA). The allelic frequencies of the selected SNPs were calculated using a gene-counting method, and Hardy-Weinberg equilibrium and linkage disequilibrium for each SNP were assessed by the 2 -test. Kolmogorov-Smirnov test was performed to assess the normality of data distribution, and several variables were log-transformed to obtain a normal distribution prior to analysis. Student's t-test and the Mann-Whitney U-test (for MPA and VPA) and the 2 -test (for categorical variables) were used to evaluate the significance of differences between the low and high CRF groups. Pearson's partial correlation analysis adjusted for age and visceral fat area and Spearman's correlation analysis for MPA and VPA were performed to determine the correlations among subject characteristics. The associations of each SNP and GRS with indices of glucose metabolism (i.e., HbA1c, HOMA-IR, and HOMA-␤) were assessed by multiple linear regression analysis adjusted for age, visceral fat area, alcohol consumption, current/former smoking status, and medication use. Multiple linear regression analysis was performed to examine the associations of V O2max and GRS with HbA1c; age, visceral fat area, V O2max, and GRS were included as independent variables, and HbA1c as the dependent variable. The model was adjusted for alcohol consumption, current/former smoking status, medication use, and the variables that exhibited a significant partial correlation with HbA1c. The influences of CRF level and GRS group on the indices of glucose metabolism were assessed by two-way analysis of covariance (ANCOVA) adjusted for the appropriate covariates. A post hoc test with Bonferroni correction was used to identify significant differences among mean values if a significant main effect or interaction was identified. All measurements and calculated values are presented as means Ϯ SD or geometric means Ϯ SD (for log-transformed variables). The level of significance was set at P Ͻ 0.05.
RESULTS
Subject characteristics. The characteristics of the study subjects are shown in Table 2 . Body fat percentage, visceral fat area, HbA1c, and triglycerides were lower in the high CRF group than in the low CRF group (P Ͻ 0.05). In addition, V O 2max , HDL cholesterol, MPA, and VPA were significantly higher in the high CRF group than in the low CRF group (P Ͻ 0.05). Spearman's correlation analysis demonstrated a strong correlation between V O 2max and VPA ( ϭ 0.503, P Ͻ 0.001) but not between V O 2max and MPA ( ϭ 0.095, P ϭ 0.245); this suggests that the high levels of CRF in this population are probably due to VPA.
Associations between SNPs and glucose metabolism. To confirm that the selected SNPs actually influenced glucose metabolism in the study population, we examined the associations of each SNP with HbA1c, HOMA-IR, and HOMA-␤ after adjusting for age, visceral fat area, alcohol consumption, smoking status, and medication use as covariates. As shown in Table 3 , the risk alleles of rs7756992 in CDKAL1, rs2383208 in CDKN2B, and rs7172432 in C2CD4A were significantly associated with high HbA1c levels (P Ͻ 0.05). The risk alleles of rs2237892 in KCNQ1 and rs5219 in KCNJ11 were significantly associated with both HOMA-IR and HOMA-␤ (P Ͻ 0.05). Furthermore, rs10830963 in MTNR1B was significantly associated with HOMA-␤ (P Ͻ 0.05). Although five of the 11 SNPs were not associated with any indexes of glucose metabolism, the GRS calculated from the 11 SNPs was positively associated with HbA1c and negatively associated with HOMA-IR and HOMA-␤ (P Ͻ 0.05).
Comparison of glucose metabolism among GRS and CRF groups. Next, we compared the glucose metabolism indexes among the GRS and CRF groups. Two-way ANCOVA adjusted Data are expressed as means Ϯ SD. Insulin, homeostasis model assessment of insulin resistance (HOMA-IR), homeostasis model assessment of ␤-cell function (HOMA-␤), HDL cholesterol, and triglycerides were log-transformed for analysis (data are shown as geometric means Ϯ SD). CRF, cardiorespiratory fitness; BMI, body mass index; V O2max, maximal oxygen uptake; FPG, fasting plasma glucose; MPA, moderate-intensity physical activity; VPA, vigorous-intensity physical activity. *Low CRF vs. high CRF. Boldface indicates statistical significance at P Ͻ 0.05. †n ϭ 154.
for possible confounders showed that in both the low and high CRF groups, HbA1c was significantly higher in the high GRS group than in the low GRS group (Fig. 1 and Table 4 ). Concordant with the association between GRS groups and HbA1c levels, subjects with a high GRS had a lower HOMA-␤ than those with a low GRS in both the low and high CRF groups. FPG, insulin, and HOMA-IR did not differ significantly among GRS or CRF groups.
Association of GRS and CRF with HbA1c. Although the results clearly show that the polygenic effects of T2DM-related SNPs on HbA1c were detectable even in individuals with high CRF levels, it remains unclear whether CRF is associated with HbA1c independent of GRS. Therefore, we performed multiple linear regression analysis with HbA1c as the dependent variable and V O 2max and GRS, as well as age and visceral fat area, which probably influence glucose metabolism, as independent variables. As shown in Table 5 , although GRS was a significant predictor of HbA1c (␤ ϭ 0.153, P ϭ 0.025), V O 2max was also negatively associated with HbA1c independently of GRS after adjusting for LDL cholesterol, alcohol consumption, current/ former smoking status, and medication use (␤ ϭ Ϫ0.240, P ϭ 0.041). However, neither age nor visceral fat area was significantly associated with HbA1c.
DISCUSSION
The main finding of this study is that although high CRF was independently associated with decreased HbA1c, the GRS calculated from T2DM-related SNPs was significantly associated with increased HbA1c and decreased HOMA-␤ even in individuals with high CRF levels. Several studies demonstrated that the GRS calculated from T2DM-associated SNPs is robustly associated with impaired insulin secretion even in nondiabetic individuals (18, 36, 44, 49a) . Meanwhile, high CRF is associated with a reduced risk of T2DM (37) . Furthermore, impaired insulin secretion is a predominant risk factor for T2DM in Asian populations, which have a lower insulin secretory capacity than Caucasian populations (30, 34) ; therefore, it is important to determine whether high CRF attenuates the polygenic risk of T2DM in the Japanese population.
T2DM is complex disease affected by multiple genetic factors, which have relatively small effects by themselves. Because the effect size of each T2DM-associated SNP identified in large-scale GWASs was small, several studies calculated GRS from GWAS-derived SNPs to assess the polygenic risks of T2DM and impaired ␤-cell function (18, 32, 33, 36, 44, 47, 49a) . Actually, although five of the 11 SNPs selected in the present study were not associated with any indexes of glucose metabolism, the GRS calculated from them was an independent predictor of HbA1c levels (Table 5 ). HbA1c reflects the mean blood glucose level over the past 2-3 mo, making it a better indicator of chronic glycemia than FPG. Therefore, these results indicate that the polygenic risk of T2DM robustly influences glucose homeostasis even in nondiabetic individuals. Furthermore, this relationship was equally observed in both the low and high CRF groups ( Fig. 1 and Table 4 ), suggesting that high CRF does not attenuate the polygenic risk of hyperglycemia.
Furthermore, the individuals with a high GRS had a lower HOMA-␤ than those with a low GRS regardless of CRF. This suggests that the difference in HbA1c levels with respect to GRS is due to impaired ␤-cell function. HOMA-␤ is an index of ␤-cell function calculated from fasting glucose and insulin; however, it does not always accurately reflect ␤-cell function because it is not adjusted for insulin sensitivity (52) . For example, nondiabetic overweight subjects with insulin resis- tance who exhibit increased compensatory insulin secretion often have higher HOMA-␤ than lean individuals. Nevertheless, insulin resistance assessed by HOMA-IR and body fat indexes such as BMI and visceral fat area did not differ significantly with respect to GRS within both the low and high CRF groups. Therefore, the difference in HOMA-␤ between GRS groups in the present study accurately reflects the difference in ␤-cell function. Because HbA1c has been shown to be a significant predictor of T2DM development (9, 40) , even individuals with high CRF may not have a completely attenuated polygenic risk of T2DM or impaired insulin secretory capacity. Although regular exercise is associated with improved ␤-cell function (13, 31, 42) , the underlying mechanisms are not fully elucidated. Nevertheless, previous studies suggested that exercise increases glucose transporter 2 content (27), improves Akt signaling and glucokinase activity (17, 27) , and increases mitochondrial respiration in pancreatic ␤-cells (17) , which may contribute to the enhancement of glucose-stimulated insulin secretion. On the other hand, the SNPs selected in the present study appear to influence ␤-cell function via mechanisms different from that of exercise. For example, the KCNJ11 gene encodes a subunit of the ATP-sensitive potassium channel, which plays an essential role in the control of insulin release from ␤-cells (2). Cdk5 regulatory subunit-associated protein 1-like (CDKAL1) is a methylthiotransferase that is necessary for modification of tRNALys (UUU). Functional loss of CD-KAL1 affects the accuracy of protein translation, causing the synthesis of abnormal insulin, which triggers ER stress in ␤-cells (53) . Therefore, it seems reasonable to speculate that regular exercise cannot compensate the ␤-cell dysfunction caused by these SNPs in the KCNJ11 and CDKAL1 genes.
A previous large-scale association study demonstrated that among T2DM-related SNPs, risk alleles related to impaired ␤-cell function are rather associated with high insulin sensitivity (51) . Concordant with this observation, interestingly, GRS was associated with increased HbA1c and decreased both HOMA-␤ and HOMA-IR in the present study. Although both impaired insulin secretion and insulin resistance are characteristic features of the pathogenesis of T2DM, their contributions differ between Asian and Caucasian populations. Caucasian T2DM patients, who generally exhibit insulin resistance associated with obesity, have a mean BMI of ϳ30 kg/m 2 (16, 35) . In contrast, the mean BMI of Japanese people with T2DM is ϳ23 kg/m 2 (43) , and these patients do not always have insulin resistance. Because Caucasians with a high insulin secretory capacity generally exhibit an insulin-resistant state prior to impaired ␤-cell function (54), most of them who have impaired insulin secretion also exhibit insulin resistance. In contrast, Asian people with low BMI often have perturbed insulin secretion without insulin resistance (49) . In the present study, which involved mainly normal-weight Japanese subjects (mean BMI: 23.6 Ϯ 2.5 kg/m 2 ), the individuals with a high GRS had high levels of HbA1c without elevated HOMA-IR, which may reflect the physiological and genetic characteristics of Asian people regarding glucose metabolism.
Nevertheless, the multiple linear regression analysis demonstrated that CRF was significantly associated with HbA1c independently of GRS and that the association was stronger than that between GRS and HbA1c (V O 2max : ␤ ϭ Ϫ0.240, P ϭ 0.041; GRS: ␤ ϭ 0.153, P ϭ 0.025) ( Table 5 ). This result suggests that regular exercise and sustained high CRF are important for preventing hyperglycemia regardless of genetic predisposition. High CRF is associated with reduced body fat, particularly visceral adiposity, which is the major contributor to insulin resistance (50, 56) . In addition, regular aerobic exercise increases the expression of glucose transporter 4 in the skeletal muscle and stimulates its translocation to the cell membrane, resulting in improved insulin sensitivity (22, 25) . In the present study, individuals with high CRF had low visceral fat area (Table 2) , and HOMA-IR was actually correlated with HbA1c in all GRS groups (data not shown), which may be partly mediated by CRF levels. Although CRF did not modify the association between GRS and ␤-cell function in the present study, it might contribute to the reduction of HbA1c levels Data are expressed as means Ϯ SD. Insulin, HOMA-IR, and HOMA-␤ were log-transformed for analysis (data are shown as geometric means Ϯ SD). Two-way ANCOVA adjusted for age, visceral fat area, current/former smoking status, alcohol consumption, and medication use as appropriate. *P Ͻ 0.05 vs. the low GRS group within the same CRF group. Boldface indicates statistical significance at P Ͻ 0.05. mainly through the improvement of insulin resistance. In a previous study, the risk of T2DM was the highest in individuals exhibiting both impaired insulin secretion and insulin resistance (34) . Therefore, individuals with a high genetic risk of impaired insulin secretory capacity should make greater efforts to increase their CRF levels in order to improve insulin resistance.
The present study has several limitations. First, the sample size was relatively small, which might have led to a type 2 error. Second, because this was a cross-sectional study, the interaction effects between CRF and polygenic risk on the incidence of T2DM were not examined. Prospective and interventional studies are required to elucidate whether CRF significantly influences the relationship between the polygenic risk of impaired ␤-cell function and incidence of T2DM. Third, the present study evaluated ␤-cell function on the basis of HOMA-␤, which does not always accurately reflect ␤-cell function as mentioned above. Although this index is useful for evaluating ␤-cell function assuming equal body composition, it might underestimate insulin secretory capacity in individuals with high CRF and high insulin sensitivity. A more accurate indicator of ␤-cell function, such as the disposition index (7), the product of oral glucose tolerance test-derived measures of insulin sensitivity and first-phase insulin secretion, should be used in future studies. Finally, CRF per se is not only influenced by regular exercise but is also determined by genetic factors (10, 11) . Therefore, individuals with high CRF in the present study possibly had the genetic advantage of better glycemic control regardless of T2DM-related SNPs, even though we confirmed that CRF was strongly associated with accelerometer-measured VPA. Thus, further studies controlling for the genetic factors associated with CRF as confounders are required to clarify the associations of acquired CRF by regular exercise with T2DM-related SNPs and glucose metabolism.
In conclusion, the present study reveals that CRF is associated with HbA1c levels independently of GRS derived from T2DM-related SNPs; however, it does not modify the association of GRS with increased HbA1c or impaired ␤-cell function.
